<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">38023981</PMID><DateRevised><Year>2023</Year><Month>12</Month><Day>01</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Electronic">2590-1133</ISSN><JournalIssue CitedMedium="Internet"><Volume>6</Volume><PubDate><Year>2023</Year><Month>Dec</Month></PubDate></JournalIssue><Title>Global epidemiology</Title><ISOAbbreviation>Glob Epidemiol</ISOAbbreviation></Journal><ArticleTitle>Post-COVID-19 syndrome: Descriptive analysis based on a survivors' cohort in Colombia.</ArticleTitle><Pagination><StartPage>100126</StartPage><MedlinePgn>100126</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">100126</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1016/j.gloepi.2023.100126</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="UNASSIGNED">The prevalence of post-COVID-19 Syndrome (PCS) is estimated to be between 10% and 20%. The main reported symptoms are fatigue, memory alterations, dyspnea, sleep disorders, arthralgia, anxiety, taste alterations, coughing and depression. This study aims to determine the prevalence of post-COVID-19 symptoms in a group of Colombian patients who were recruited during their outpatient appointments.</AbstractText><AbstractText Label="METHODOLOGY" NlmCategory="UNASSIGNED">This cross-sectional study was conducted between December 2021 to May 2022. It included patients from outpatient facilities located in five main cities in Colombia who were positive for SARS-CoV-2 infection detected by reverse transcription-polymerase chain reaction (RT-PCR) testing and reported PCS in the following 12&#xa0;weeks after their COVID-19 diagnosis.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">A total of 1047 individuals &gt;18&#xa0;years old met the inclusion criteria and were included in the study. The median age was 46&#xa0;years old. 68.2% of the participants were female, 41.5% of the patients reported having a pre-existent condition (hypertension, anxiety disorder, diabetes, hyperthyroidism, obesity and asthma). Only 22% had received at least one dose of COVID-19 vaccine prior to the COVID-19 episode registered. The more prevalent symptoms within our group are described as follows: fatigue (53.3%), dyspnea (40.3%), arthralgia and/or myalgia (43%), cephalea (40.5%), sleep disorders (35.7%) and coughing (31.3%). 72% of the patients presented four or more post-COVID 19 symptoms, 9% two symptoms, and 10% only one symptom.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="UNASSIGNED">The findings of this study are consistent with international literature publicly available. The distribution and prevalence of post-COVID symptoms highlight the importance of further research to improve understanding and its potential consequences and implications in terms of quality of life and health care planning services.</AbstractText><CopyrightInformation>&#xa9; 2023 Published by Elsevier Inc.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Romero</LastName><ForeName>Martin</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Grupo Proyectame, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Caicedo</LastName><ForeName>Martha</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Grupo Proyectame, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D&#xed;az</LastName><ForeName>Andrea</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Grupo Proyectame, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ortega</LastName><ForeName>Delia</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Epidemiologist, Departamento de salud P&#xfa;blica, Universidad del Valle, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llanos</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Divisi&#xf3;n M&#xe9;dico Cient&#xed;fica, Tecnoqu&#xed;micas, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Concha</LastName><ForeName>Alejandro</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Gastroenterology, Cl&#xed;nica del Country, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vallejo</LastName><ForeName>Andr&#xe9;s</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Otolaryngologist, Cl&#xed;nica del Country, Bogot&#xe1;, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vald&#xe9;s</LastName><ForeName>Fernando</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Orthopedic traumatology, Centro M&#xe9;dico Imbanaco, Cali, Colombia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gonz&#xe1;lez</LastName><ForeName>C&#xe9;sar</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Psychiatry, Centro M&#xe9;dico Imbanaco, Cali, Colombia.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>27</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Glob Epidemiol</MedlineTA><NlmUniqueID>101759263</NlmUniqueID><ISSNLinking>2590-1133</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Long COVID</Keyword><Keyword MajorTopicYN="N">Post-COVID-19 syndrome</Keyword><Keyword MajorTopicYN="N">Prevalence</Keyword></KeywordList><CoiStatement>This study was funded by Tecnoqu&#xed;micas, however, the literature search, study development, and interpretation of results were conducted independently and objectively by the authors. The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>6</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2023</Year><Month>10</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>10</Month><Day>24</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>43</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>18</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>11</Month><Day>29</Day><Hour>16</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>27</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">38023981</ArticleId><ArticleId IdType="pmc">PMC10643089</ArticleId><ArticleId IdType="doi">10.1016/j.gloepi.2023.100126</ArticleId><ArticleId IdType="pii">S2590-1133(23)00029-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>National Institute for Health and Care Excellence (NICE) SIGN (SIGN) and RC of GP (RCGP) 2022. Covid19 Rapid Guideline: Managing the Longterm Effects of Covid19. National Institute for Health and Care Excellence (NICE), Scottish Intercollegiate Guidelines Network (SIGN) and Royal College of General Practitioners (RCGP) pp. 1&#x2013;106.</Citation></Reference><Reference><Citation>World Healtn Organizarion . 2021. A clinical case definition of post COVID-19 condition by a Delphi consensus data accessed:2021-12-23. WHO/2019-nCoV/Post_COVID-19_condition/Clinical_case_definition/2021.1.</Citation></Reference><Reference><Citation>Umesh A., Pranay K., Pandey R.C., Gupta M.K. Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism. Infection. 2022;50:1053&#x2013;1066.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9055372</ArticleId><ArticleId IdType="pubmed">35489015</ArticleId></ArticleIdList></Reference><Reference><Citation>Michelen M., Sigfrid L., Kartsonaki C., Shemilt I., Hastie C., O&#x2019;hara M., et al. Characterising long COVID: a living systematic review. BMJ Global Health. 2021;6(9)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8478580</ArticleId><ArticleId IdType="pubmed">34580069</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C., Haupert S.R., Zimmermann L., Shi X., Fritsche L.G., Mukherjee B. Global prevalence of post-coronavirus disease 2019 (COVID-19) condition or long COVID: a meta-analysis and systematic review. J Infect Dis. 2022;226(9):1593&#x2013;1607.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9047189</ArticleId><ArticleId IdType="pubmed">35429399</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen N.N., Hoang V.T., Dao T.L., Dudouet P., Eldin C., Gautret P. Clinical patterns of somatic symptoms in patients suffering from post-acute long COVID: a systematic review. Eur J Clin Microbiol Infect Dis. 2022;41(4):515&#x2013;545.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8830952</ArticleId><ArticleId IdType="pubmed">35142947</ArticleId></ArticleIdList></Reference><Reference><Citation>Thompson E.J., Williams D.M., Walker A.J., Mitchell R.E., Niedzwiedz C.L., Yang T.C., et al. Long COVID burden and risk factors in 10 UK longitudinal studies and electronic health records. Nat Commun. 2022;13(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9240035</ArticleId><ArticleId IdType="pubmed">35764621</ArticleId></ArticleIdList></Reference><Reference><Citation>Whitaker M., Elliott J., Chadeau-Hyam M., Riley S., Darzi A., Cooke G., et al. Persistent COVID-19 symptoms in a community study of 606,434 people in England. Nat Commun. 2022;13(1):1&#x2013;10.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9005552</ArticleId><ArticleId IdType="pubmed">35413949</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim Y., Kim S.E., Kim T., Yun K.W., Lee S.H., Lee E., et al. Preliminary guidelines for the clinical evaluation and management of long COVID. Infect Chemother. 2022;54(3):566.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9533168</ArticleId><ArticleId IdType="pubmed">36196612</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO. Coronavirus disease (COVID-19): Post COVID-19 condition [Internet]. [cited 2022 Nov 23]. Available from: https://www.who.int/news-room/questions-and-answers/item/coronavirus-disease-(covid-19)-post-covid-19-condition?gclid=EAIaIQobChMIlsyllqHF-wIVFNGGCh1g7wWxEAAYASAAEgI8EfD_BwE.</Citation></Reference><Reference><Citation>Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11(1)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352980</ArticleId><ArticleId IdType="pubmed">34373540</ArticleId></ArticleIdList></Reference><Reference><Citation>The prevalence of long COVID symptoms and COVID-19 complications - Office for National Statistics [Internet]. [cited 2021 Aug 10]. Available from: https://www.ons.gov.uk/news/statementsandletters/theprevalenceoflongcovidsymptomsandcovid19complications.</Citation></Reference><Reference><Citation>Kish L. John Wiley &amp; Sons, Inc; New York, London: 1965. Survey sampling. IX + 643 S., 31 Abb., 56 Tab., Preis 83 s. [Internet]. [cited 2021 Aug 10]. Available from: https://onlinelibrary.wiley.com/doi/epdf/10.1002/bimj.19680100122.</Citation></Reference><Reference><Citation>Colombia M de saud de. Ministerio de salud Resolucion numero 8430 de 1993. Minist Salud. 2012;32(4):471&#x2013;473.</Citation></Reference><Reference><Citation>Congreso de Colombia . 2012. Ley Estatutaria 1581 De 2012.  https://www.unicauca.edu.co/versionP/sites/default/files/files/LEY_1581_DE_2012.pdf.</Citation></Reference><Reference><Citation>Alvarez-Moreno C.A., Pineda J., Bare&#xf1;o A., Espitia R., Rengifo P. Long COVID-19 in Latin America: low prevalence, high resilience or low surveillance and difficulties accessing health care? Travel Med Infect Dis. 2023;51(November 2022)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9640373</ArticleId><ArticleId IdType="pubmed">36368518</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J.M., Rojas M., Salinas M.L., Rodr&#xed;guez Y., Roa G., Lozano M., et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. 2021;20(11)</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>de Miranda D.A.P., Gomes S.V.C., Filgueiras P.S., Corsini C.A., Almeida N.B.F., Silva R.A., et al. Long COVID-19 syndrome: a 14-months longitudinal study during the two first epidemic peaks in Southeast Brazil. Trans R Soc Trop Med Hyg. 2022;116(11):1007&#x2013;1014.</Citation><ArticleIdList><ArticleId IdType="pubmed">35514142</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>